ITPRIPL1 and central nervous system cancer: This study reveals that ITPRIPL1 plays a dual role in glioma: It suppresses T cell–mediated immune responses, contributing to an immunosuppressive microenvironment, and interferes with the efficacy of antitumor drugs, thereby promoting tumor progression and ultimately leading to poor patient prognosis.